Trial intelligence / Profile preview

Effects of CD11891D, CD12681D, CD12455G, and CD12446E in a psoriasis transplant model

NL-OMON43107Active, not recruiting

Sponsor
Derphartox
Start
Apr 2016
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Trial of tazarotene and tofacitinib in psoriasis (4 arms), sponsored by Derphartox. Started Apr 2016; status: active, not recruiting.

02

Drugs

tazarotenetofacitinib
03

Conditions

psoriasis

Beyond the preview

Go deeper on NL-OMON43107.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON43107.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call